20% reduction in workforce.
All entries for: Rare Disease
March 18, 2025
Pyxis Oncology
Layoffs
Boston, MA
1-50 employees
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
March 13, 2025
Sutro Biopharma
Layoffs
South San Francisco, CA
201-500 employees
Reducing headcount by nearly 50 percent.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
March 11, 2025
Kiromic Biopharma
Layoffs
Houston, TX
1-50 employees
Furloughed substantially all of its workforce.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
March 6, 2025
Atea Pharmaceuticals
Layoffs
Boston, MA
51-200 employees
25% reduction in workforce.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
March 5, 2025
ALX Oncology
Layoffs
San Francisco, CA
51-200 employees
ALX Oncology, a Bay Area biotech firm currently running clinical trials for its anticancer therapy, announced Wednesday that it’s laying off about 30% of its staff.
Disease Area: Multiple, Oncology, Rare Diseases
Drug Type: Small Molecule
February 28, 2025
CRISPR Therapeutics
Layoffs
Switzerland
51-200 employees
Laying off an undisclosed number of employees.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
February 25, 2025
Lava Therapeutics
Layoffs
Netherlands
51-200 employees
Laying off 30% of its staff.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
February 13, 2025
Encoded Therapeutics
Layoffs
South San Francisco, CA
51-200 employees
29% reduction in workforce, mostly in technology and early-stage R&D functions.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
February 5, 2025
X4 Pharmaceuticals
Layoffs
Boston, MA
51-200 employees
43 employees laid off. All pre-clinical programs paused.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
February 4, 2025
Bristol Myers Squibb
Layoffs
Princeton, NJ
10,001-50,000 employees
67 employees laid off in New Jersey.
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
